February 1, 2016
GenArraytion Self Funds Development of Zika Test
Rockville based GenArraytion, Inc. announced that it self-funded the development of the first commercially available polymerase chain reaction (PCR)-based molecular test to identify the Zika virus, a fever-causing disease transmitted by the Aedes aegypti mosquito. The Zika virus test works with an existing GenArraytion MultiFLEX™ Bioassay panel that targets viruses causing dengue fever, yellow fever and Chikungunya, which are also carried by this mosquito and are known to cause febrile disease in humans.
“Maryland’s innovation economy has a strong history of responding to major public health issues, and it is a great source of pride for our region that one of our members, GenArraytion, has rapidly developed a critical test in finding a solution to the Zika virus,” says Phil Schiff, CEO of the Tech Council of Maryland.
For the complete press release click here.